ArticleCancers2021

Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer.

Zainab Al-Taie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.